Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 6.50
+0.08 (1.25%)
Jun 11, 2026, 5:29 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 171.34 million as of June 11, 2026. Its market cap has decreased by -11.06% in one year.
Market Cap
171.34M
Enterprise Value
107.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.50
Market Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has increased from 6.93M to 171.34M, an increase of 2,372.35%. That is a compound annual growth rate of 12.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 169.24M | 39.57% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 228.19M |
| Xbrane Biopharma AB | 212.24M |
| Initiator Pharma | 184.82M |
| Xintela AB | 172.25M |
| Elicera Therapeutics AB | 169.51M |
| Diamyd Medical AB | 167.69M |
| Nanologica AB | 167.02M |
| AlzeCure Pharma AB | 159.16M |